Femtomolar concentrations of dextromethorphan protect mesencephalic dopaminergic neurons from inflammatory damage
Open Access
- 1 April 2005
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 19 (6) , 489-496
Abstract
Inflammation in the brain has increasingly been recognized to play an important role in the pathogenesis of several neurodegenerative disorders, including Parkinson's disease (PD). Progress in the search for effective therapeutic strategies that can halt this degenerative process remains limited. We previously showed that micromolar concentrations of dextromethorphan (DM), a major ingredient of widely used antitussive remedies, reduced the inflammation‐mediated degeneration of dopaminergic neurons through the inhibition of microglial activation. In this study, we report that femto‐ and micromolar concentrations of DM (both pre‐ and post‐treatment) showed equal efficacy in protecting lipopolysaccharide (LPS)‐induced dopaminergic neuron death in midbrain neuron‐glia cultures. Both concentrations of DM decreased LPS‐induced release of nitric oxide, tumor necrosis factor‐α, prostaglandin E 2 and superoxide from microglia in comparable degrees. The important role of superoxide was demonstrated by DM's failure to show a neuroprotective effect in neuron‐glia cultures from NADPH oxidase‐deficient mice. These results suggest that the neuroprotective effect elicited by femtomolar concentrations of DM is mediated through the inhibition of LPS‐induced proinflammatory factors, especially superoxide. These findings suggest a novel therapeutic concept of using “ultra‐low” drug concentrations for the intervention of inflammation‐related neurodegenerative diseases.—Li, G., Cui, G., Tzeng, N.‐S., Wei, S.‐J., Wang, T., Block, M. L., Hong, J.‐S. Femtomolar concentrations of dextromethorphan protect mesencephalic dopaminergic neurons from inflammatory damage. FASEB J . 19, 489–496 (2005)Keywords
This publication has 35 references indexed in Scilit:
- Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic InterventionThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Antiapoptotic and cytotoxic properties of delta opioid peptide [D‐Ala2,D‐Leu5]enkephalin in PC12 cellsSynapse, 2001
- Delayed Systemic Administration of PACAP38 Is Neuroprotective in Transient Middle Cerebral Artery Occlusion in the RatStroke, 2000
- Microglia and the Immune Pathology of Alzheimer DiseaseThe American Journal of Human Genetics, 1999
- Dextromethorphan protects against cerebral injury following transient, but not permanent, focal ischemia in ratsLife Sciences, 1997
- Inhibition of the respiratory burst in mouse macrophages by ultra-low doses of an opioid peptide is consistent with a possible adaptation mechanismFEBS Letters, 1994
- Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's diseaseGlia, 1993
- Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits.Stroke, 1988
- Morphinans attenuate cortical neuronal injury induced by glucose deprivation in vitroBrain Research, 1988
- Dynorphin(1–13) improves survival in cats with focal cerebral ischaemiaNature, 1984